Literature DB >> 24772246

Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility.

Tokiko Nagamura-Inoue1, Haiping He1.   

Abstract

Human umbilical cord (UC) is a promising source of mesenchymal stem cells (MSCs). Apart from their prominent advantages, such as a painless collection procedure and faster self-renewal, UC-MSCs have shown the ability to differentiate into three germ layers, to accumulate in damaged tissue or inflamed regions, to promote tissue repair, and to modulate immune response. There are diverse protocols and culture methods for the isolation of MSCs from the various compartments of UC, such as Wharton's jelly, vein, arteries, UC lining and subamnion and perivascular regions. In this review, we give a brief introduction to various compartments of UC as a source of MSCs and emphasize the potential clinical utility of UC-MSCs for regenerative medicine and immunotherapy.

Entities:  

Keywords:  Immunotherapy; Mesenchymal stem cells; Multipotency; Umbilical cord; Wharton’s Jelly

Year:  2014        PMID: 24772246      PMCID: PMC3999777          DOI: 10.4252/wjsc.v6.i2.195

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  67 in total

1.  Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Authors:  Marjolijn Duijvestein; Anne Christine W Vos; Helene Roelofs; Manon E Wildenberg; Barbara B Wendrich; Henricus W Verspaget; Engelina M C Kooy-Winkelaar; Frits Koning; Jaap Jan Zwaginga; Herma H Fidder; Auke P Verhaar; Willem E Fibbe; Gijs R van den Brink; Daniel W Hommes
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

2.  Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential.

Authors:  Pieternella S in 't Anker; Willy A Noort; Sicco A Scherjon; Carin Kleijburg-van der Keur; Alwine B Kruisselbrink; Rutger L van Bezooijen; Willem Beekhuizen; Roelof Willemze; Humphrey H H Kanhai; Willem E Fibbe
Journal:  Haematologica       Date:  2003-08       Impact factor: 9.941

3.  Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord.

Authors:  Ingrida Majore; Pierre Moretti; Frank Stahl; Ralf Hass; Cornelia Kasper
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

4.  Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium.

Authors:  Massimiliano Gnecchi; Luis G Melo
Journal:  Methods Mol Biol       Date:  2009

5.  Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue.

Authors:  Xiaohong Zhang; Masako Hirai; Susana Cantero; Rodica Ciubotariu; Ludy Dobrila; Allen Hirsh; Koichi Igura; Hitoshi Satoh; Izuru Yokomi; Toshihide Nishimura; Satoru Yamaguchi; Kotaro Yoshimura; Pablo Rubinstein; Tsuneo A Takahashi
Journal:  J Cell Biochem       Date:  2011-04       Impact factor: 4.429

6.  Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo.

Authors:  C Y Fong; K Gauthaman; S Cheyyatraivendran; H D Lin; A Biswas; A Bongso
Journal:  J Cell Biochem       Date:  2012-02       Impact factor: 4.429

7.  Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells.

Authors:  Chui-Yee Fong; Li-Ling Chak; Arijit Biswas; Jee-Hian Tan; Kalamegam Gauthaman; Woon-Khiong Chan; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

8.  Human umbilical cord provides a significant source of unexpanded mesenchymal stromal cells.

Authors:  Akie Kikuchi-Taura; Akihiko Taguchi; Takayoshi Kanda; Takayuki Inoue; Yukiko Kasahara; Haruka Hirose; Iori Sato; Tomohiro Matsuyama; Takayuki Nakagomi; Kenichi Yamahara; David Stern; Hiroyasu Ogawa; Toshihiro Soma
Journal:  Cytotherapy       Date:  2012-02-20       Impact factor: 5.414

9.  Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.

Authors:  David Campard; Philippe A Lysy; Mustapha Najimi; Etienne Marc Sokal
Journal:  Gastroenterology       Date:  2007-12-23       Impact factor: 22.682

10.  Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro study.

Authors:  A Marmotti; S Mattia; M Bruzzone; S Buttiglieri; A Risso; D E Bonasia; D Blonna; F Castoldi; R Rossi; C Zanini; E Ercole; E Defabiani; C Tarella; G M Peretti
Journal:  Stem Cells Int       Date:  2012-03-07       Impact factor: 5.443

View more
  103 in total

1.  Enhanced viability and neural differential potential in poor post-thaw hADSCs by agarose multi-well dishes and spheroid culture.

Authors:  Xiaoling Guo; Shanyi Li; Qingshan Ji; Ruiling Lian; Jiansu Chen
Journal:  Hum Cell       Date:  2015-06-09       Impact factor: 4.174

2.  The effect of extended passaging on the phenotype and osteogenic potential of human umbilical cord mesenchymal stem cells.

Authors:  Zhe Shi; Liang Zhao; Gengtao Qiu; Ruixuan He; Michael S Detamore
Journal:  Mol Cell Biochem       Date:  2015-01-03       Impact factor: 3.396

Review 3.  Biological functions of mesenchymal stem cells and clinical implications.

Authors:  Abderrahim Naji; Masamitsu Eitoku; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Narufumi Suganuma
Journal:  Cell Mol Life Sci       Date:  2019-05-04       Impact factor: 9.261

Review 4.  Cell-based endometrial regeneration: current status and future perspectives.

Authors:  Neda Keyhanvar; Nosratollah Zarghami; Nathalie Bleisinger; Hamed Hajipour; Amir Fattahi; Mohammad Nouri; Ralf Dittrich
Journal:  Cell Tissue Res       Date:  2021-03-02       Impact factor: 5.249

5.  Cytokines in umbilical cord blood-derived cellular product: a mechanistic insight into bone repair.

Authors:  Mukta S Sane; Neha Misra; Omid Mohammad Mousa; Steve Czop; Huiyuan Tang; Larry T Khoo; Christopher D Jones; Soumyajit Banerjee Mustafi
Journal:  Regen Med       Date:  2018-10-22       Impact factor: 3.806

6.  Transplanted Umbilical Cord Mesenchymal Stem Cells Modify the In Vivo Microenvironment Enhancing Angiogenesis and Leading to Bone Regeneration.

Authors:  Maria Rosa Todeschi; Rania El Backly; Chiara Capelli; Antonio Daga; Eugenio Patrone; Martino Introna; Ranieri Cancedda; Maddalena Mastrogiacomo
Journal:  Stem Cells Dev       Date:  2015-03-18       Impact factor: 3.272

Review 7.  Discarded Wharton jelly of the human umbilical cord: a viable source for mesenchymal stromal cells.

Authors:  Nate Watson; Ryan Divers; Roshan Kedar; Ankur Mehindru; Anuj Mehindru; Mia C Borlongan; Cesar V Borlongan
Journal:  Cytotherapy       Date:  2014-10-18       Impact factor: 5.414

8.  Reversibly immortalized human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are responsive to BMP9-induced osteogenic and adipogenic differentiation.

Authors:  Yi Shu; Chao Yang; Xiaojuan Ji; Linghuan Zhang; Yang Bi; Ke Yang; Mengjia Gong; Xing Liu; Qi Guo; Yuxi Su; Xiangyang Qu; Guoxin Nan; Chen Zhao; Zongyue Zeng; Xinyi Yu; Ruyi Zhang; Shujuan Yan; Jiayan Lei; Ke Wu; Ying Wu; Liping An; Shifeng Huang; Cheng Gong; Chengfu Yuan; Wei Liu; Bo Huang; Yixiao Feng; Bo Zhang; Zhengyu Dai; Yi Shen; Wenping Luo; Xi Wang; Rex C Haydon; Hue H Luu; Russell R Reid; Jennifer Moriatis Wolf; Michael J Lee; Tong-Chuan He; Yasha Li
Journal:  J Cell Biochem       Date:  2018-08-04       Impact factor: 4.429

Review 9.  Stem cell therapy in intracerebral hemorrhage rat model.

Authors:  Marcos F Cordeiro; Ana P Horn
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

10.  Immunosuppressive properties of Wharton's jelly-derived mesenchymal stromal cells in vitro.

Authors:  Haiping He; Tokiko Nagamura-Inoue; Atsuko Takahashi; Yuka Mori; Yuki Yamamoto; Takahisa Shimazu; Hajime Tsunoda; Arinobu Tojo
Journal:  Int J Hematol       Date:  2015-07-31       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.